Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA

Br J Cancer. 1997;75(3):348-53. doi: 10.1038/bjc.1997.57.

Abstract

We investigated the effects of low-dose eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on the incidence and growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in rats fed a high-fat (HF) diet. We also examined the effects of these treatments on the fatty acid composition of tumour and serum. Tumour incidence was significantly decreased by the administration of low-dose EPA and DHA, whereas their inhibitory effects on tumour growth did not reach significance. Serum arachidonic acid (AA) level was decreased by the administration of low-dose EPA and tended to be decreased by the administration of low-dose DHA, whereas tumour AA levels were not changed. The administration of low-dose EPA and DHA may be useful for inhibiting the incidence of breast cancer.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Anticarcinogenic Agents / therapeutic use*
  • Body Weight
  • Carcinogens
  • Cell Division
  • Diet, Fat-Restricted
  • Dietary Fats
  • Docosahexaenoic Acids / therapeutic use*
  • Eicosapentaenoic Acid / therapeutic use*
  • Fatty Acids, Nonesterified / blood
  • Female
  • Mammary Neoplasms, Experimental / chemically induced
  • Mammary Neoplasms, Experimental / pathology
  • Mammary Neoplasms, Experimental / prevention & control*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anticarcinogenic Agents
  • Carcinogens
  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Docosahexaenoic Acids
  • 9,10-Dimethyl-1,2-benzanthracene
  • Eicosapentaenoic Acid